22 Pharmacists can play a pivotal role in addressing these challenges by proactively discussing medication access with patients and tailoring solutions based on individual factors such as drug type, indication, insurance coverage, and personal circumstances
It represents a strategic evolution in therapeutic development, moving beyond single-target approaches to multi-receptor agonism
A typical tapering protocol reduces the dose by 25 to 50% every four weeks, mirroring the same step-down intervals used during dose escalation
(58:04) Speculating on the smear campaign against GLP-1s
Explore the latest evidence and what it means for specialty pharmacy: specialtypharmacycontinuum.com/a/eTwBAA/t #GLP1 #MASLD #MASH #Pharmacy
Conclusion Retatrutide represents a groundbreaking advancement in obesity and T2D management, with phase 2 trials demonstrating unprecedented weight loss (up to 24.2% at 48 weeks) and glycemic control (HbA1c reductions up to 2.0%)